Oramed Pharmaceuticals, Inc., a developer of alternative drug delivery systems, reported results for the recently completed Phase 2b non-FDA clinical trial of its flagship oral insulin capsule, ORMD-0801….

Early trial finds technique is safe, improves blood sugar control….

The risk for insulin resistance and diabetes grows as we age. A new report in Cell Metabolism, reveals a new contributor to the problem: the muscles of elderly people and of people with Type 2 diabetes contain lower concentrations of a protein known as PARL (short for “presenilin-associated rhomboid-like”)….

Results from a phase 3, multicenter study of triple- versus dual-combination, fixed-dose antihypertensive therapy in patients with moderate to severe hypertension showed superiority for triple-combination therapy….

Long suspected of worsening artery damage in patients with diabetes, insulin instead protects blood vessels, a new study by Joslin Diabetes Center scientists indicates…. 

Researchers found that healthy people who had just one night of short sleep can show signs of insulin resistance, a condition that often precedes Type 2 diabetes….

Consuming more nuts appears to be associated with improvements in blood cholesterol levels, according to a pooled analysis of data from 25 trials…. 

In patients with hypertension and Type 2 diabetes, relatively modest improvements in fitness status — significantly with walking just 30 minutes a day — reduces mortality risk, according to a new study….

The FDA announced that it’s reviewing the safety of a class of prostate cancer drugs, following up on data that suggest an increased risk of diabetes and certain heart problems….

Amylin Pharmaceuticals Inc said its resubmission for approval of a diabetes drug was classified by U.S. health regulators as a class 2 response, which typically suggests a review period of six months.…